Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (241-250 of 358) with videos related to

Pageof 36
Sort By:
AIDS Research and Human Retroviruses|October 27, 2007
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressureRoberta D'Arrigo, Massimo Ciccozzi, Caterina Gori, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-RitonavirEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Viruses|March 6, 2021
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic PatientsMattia Trunfio, Francesco Venuti, Francesca Alladio, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2023
Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS KitJacopo Mula, Francesco Chiara, Alessandra Manca, et al.
Plos One|October 8, 2016
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical PracticeSilvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Infectious Diseases and Therapy|March 3, 2021
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir TherapyMassimo Andreoni, Giovanni Di Perri, Marcello Persico, et al.
Metabolites|December 23, 2022
Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic StudyJessica Cusato, Alberto Borghetti, Elisabetta Teti, et al.
International Journal of Environmental Research and Public Health|July 20, 2021
Drug-Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World StudyAlessandra Mangia, Francesco Scaglione, Pierluigi Toniutto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 21, 2013
Recent outbreak of aseptic meningitis in Italy due to Echovirus 30 and phylogenetic relationship with other European circulating strainsMaria Grazia Milia, Francesco Cerutti, Gabriella Gregori, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 17, 2018
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patientsJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Pageof 36

Showing results (241-250 of 358) with videos related to

Sort By:
Pageof 36
AIDS Research and Human Retroviruses|October 27, 2007
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressureRoberta D'Arrigo, Massimo Ciccozzi, Caterina Gori, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-RitonavirEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Viruses|March 6, 2021
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic PatientsMattia Trunfio, Francesco Venuti, Francesca Alladio, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2023
Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS KitJacopo Mula, Francesco Chiara, Alessandra Manca, et al.
Plos One|October 8, 2016
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical PracticeSilvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Infectious Diseases and Therapy|March 3, 2021
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir TherapyMassimo Andreoni, Giovanni Di Perri, Marcello Persico, et al.
Metabolites|December 23, 2022
Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic StudyJessica Cusato, Alberto Borghetti, Elisabetta Teti, et al.
International Journal of Environmental Research and Public Health|July 20, 2021
Drug-Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World StudyAlessandra Mangia, Francesco Scaglione, Pierluigi Toniutto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 21, 2013
Recent outbreak of aseptic meningitis in Italy due to Echovirus 30 and phylogenetic relationship with other European circulating strainsMaria Grazia Milia, Francesco Cerutti, Gabriella Gregori, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 17, 2018
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patientsJessica Cusato, Amedeo De Nicolò, Lucio Boglione, et al.
Pageof 36